705939-73-7

Basic information

• Product Name: Benzenepropanoic acid, b-oxo-4-(phenylmethoxy)-, methyl ester
• CAS NO: 705939-73-7
• Molecular Formula: C17H16O4
• Molecular Weight: 284.312
• Mol File: 705939-73-7.mol

Chemical Properties

• Boiling Point: 426.2±25.0 °C(Predicted)
• Density: 1.174±0.06 g/cm3(Predicted)
• CAS DataBase Reference: Benzenepropanoic acid, b-oxo-4-(phenylmethoxy)-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Benzenepropanoic acid, b-oxo-4-(phenylmethoxy)-, methyl ester(705939-73-7)
• EPA Substance Registry System: Benzenepropanoic acid, b-oxo-4-(phenylmethoxy)-, methyl ester(705939-73-7)

Safety Data

• Hazardous Substances Data: 705939-73-7(Hazardous Substances Data)

Upstream product

• 54696-05-8 4'-benzyloxy-acetophenone 
• 616-38-6 carbonic acid dimethyl ester 
• 105-58-8 Diethyl carbonate 
• 100-39-0 benzyl bromide 

Downstream Products

• 1202577-75-0 (1S)-1-(4-benzyloxyphenyl)propan-1,3-diol 
• 1202577-76-1 (1S)-1-(4-benzyloxyphenyl)-3-(triisopropylsilyloxy)propan-1-ol 
• 1202577-78-3 4-{(1S)-1-ethoxy-3-[(triisopropylsilyl)oxy]propyl}phenol 
• 1202577-80-7 (3S)-3-(4-{[(1R)-4-chloro-2,3-dihydro-1H-inden-1-yl]oxy}phenyl)-3-ethoxypropan-1-ol 
• 1202577-83-0 (3S)-3-ethoxy-3-(4-{[(1R)-4-(trifluoromethyl)-2,3-dihydro-1H-inden-1-yl]oxy}phenyl)propan-1-ol 
• 1202577-96-5 {[(3S)-3-Ethoxy-3-(4-{[(1R)-5-fluoro-4-(trifluoromethyl)-2,3-dihydro-1H-inden-1-yl]oxy}phenyl)propyl]oxy}(triisopropyl)silane 
• 1202577-97-6 (3S)-3-Ethoxy-3-(4-{[(1R)-5-fluoro-4-(trifluoromethyl)-2,3-dihydro-1H-inden-1-yl]oxy}phenyl)propan-1-ol 
• 1202577-99-8 (3S)-3-Ethoxy-3-(4-{[(1R)-4-ethyl-2,3-dihydro-1H-inden-1-yl]oxy}phenyl)propan-1-ol 
• 1202578-01-5 (3S)-3-Ethoxy-3-(4-{[(1R)-4-methyl-2,3-dihydro-1H-inden-1-yl]oxy}phenyl)propan-1-ol 
• 1202578-07-1 (3S)-3-(4-{[(1R)-4-(Difluoromethyl)-2,3-dihydro-1H-inden-1-yl]oxy}phenyl)-3-ethoxypropan-1-ol 
• 1202578-17-3 {[(3S)-3-(4-{[(1R)-4,6-Dimethyl-2,3-dihydro-1H-inden-1-yl]oxy}phenyl)-3-ethoxypropyl]oxy}(triisopropyl)silane 
• 1202578-18-4 (3S)-3-(4-{[(1R)-4,6-Dimethyl-2,3-dihydro-1H-inden-1-yl]oxy}phenyl)-3-ethoxypropan-1-ol 
• 1202578-24-2 (3S)-3-(4-{[(1R)-4-Cyclopropyl-2,3-dihydro-1H-inden-1-yl]oxy}phenyl)-3-ethoxypropan-1-ol 
• 1202575-66-3 (3S)-3-(4-{[(1R)-4-chloro-2,3-dihydro-1H-inden-1-yl]oxy}phenyl)-3-ethoxypropanoic acid 

Relevant articles and documents

One-pot synthesis of β-O-4 lignin models: Via the insertion of stable 2-diazo-1,3-dicarbonyls into O-H bonds

Because lignin is a macromolecule that is a sustainable source of aromatic compounds, model substrates are commonly used to increase our understanding of its complex structure. However, few methods have been described for the synthesis of these models. Herein, we describe a new route towards the synthesis of β-O-4 lignin models by intermolecular O-H insertion reactions with simple and stable diazocarbonyls. The benefits of this developed method were shorter reaction times and high yields, as well as mild and environmentally friendly conditions. This journal is

Biocatalytic Synthesis of Enantiopure β-Methoxy-β-arylalanine Derivatives

Chiral β-hydroxy-β-arylalanine and β-methoxy-β-arylalanine derivatives, which occur widely in marine nature products, were stereoselectively synthesized with 99 % ee values. The two erythro isomers were prepared by L- or D-aminoacylase-catalyzed resolution of the corresponding N-acetyl derivatives, whereas the two threo isomers were obtained only by D-aminoacylase-catalyzed resolution of the derivatives. erythro-β-Hydroxy-β-arylalanine derivatives were prepared by diastereoselective hydrogenation of ethyl 2-(hydroxyimino)-3-oxo-3-arylpropanoates, which were in turn acquired by the oximation of ethyl 3-oxo-3-arylpropanoates with ethyl nitrite in the presence of nano-K2CO3 with yields of 72 % to 80 %. β-Methoxy-β-arylalanine derivatives were synthesized through Williamson reactions between the corresponding β-hydroxy-β-arylalanines and iodomethane with silver oxide as base.

AGONISTS OF GPR40

The present invention relates to compounds that have the ability to modulate the activity of GPR40 and are there-fore useful in the treatment of GPR40 related disorders. In addition the invention relates to the compounds, methods for their preparation, pharmaceutical compositions containing the compounds and the uses of these compounds in the treatment of certain disorders related to GPR40 activity.

Pyrazole derivatives

A compound of the formula (I): wherein R1 is hydrogen or lower alkyl; R2 is lower alkyl, etc.; R3 is lower alkoxy, etc.; R4 is hydroxy, etc.; X is O, S, etc.; Y is CH or N; Z is lower alkylene or lower alkenylene; and m is 0 or 1; or salts thereof, which are useful as a medicament.